Important safety information for people with diabetes in possession of NovoPen® Echo® and/or NovoPen® 5
PLEASE VIEW THE ATTACHED PDF DOCUMENT at base of thread for FULL details
Novo Nordisk A/S has detected that the insulin cartridge holder used in a number of NovoPen® Echo® and NovoPen® 5 batches may crack or break if exposed to certain chemicals in some household products, such as cleaning agents, sunscreen and food grease. NovoPen® Echo® and NovoPen® 5 are used for insulin treatment by people with diabetes. Novo Nordisk is already in contact with the MHRA regarding this.
Novo Nordisk urges people with diabetes using a NovoPen® Echo® and/or NovoPen® 5 from one of the affected batches to contact Novo Nordisk in order to replace the cartridge holder as some could be damaged.
A picture of the cartridge holder is shown in Figure 1.

Figure 1. Cartridge holder used for NovoPen® Echo® and NovoPen® 5.
Description of the problem:
If the cartridge holder comes in contact with certain chemicals it can crack or break. The reason for the cracking is that the plastic materials used for the cartridge holders in the affected batches can be weakened if exposed to certain chemicals found in some household products such as cleaning agents, sunscreen and food grease.
When cleaning the device as described in Instructions For Use, cracking of the cartridge holder is extremely unlikely.
Using a pen with a cracked/broken cartridge holder could result in the device delivering a smaller than intended insulin dose leading to an increase in blood sugar. The risk of experiencing high blood sugar with the use of a device with an affected cartridge holder is evaluated to be less than 0.1 %, i.e. only 1 in 1000 patients will experience high blood sugar due to an affected cartridge holder.
The warning symptoms of high blood sugar (hyperglycaemia) normally appear gradually and can be flushed, dry skin; feeling sleepy or tired; dry mouth, fruity (acetone) breath; urinating more often, feeling thirsty; losing your appetite, feeling or being sick (nausea or vomiting).
PLEASE VIEW THE ATTACHED PDF DOCUMENT (below) FOR DETAILS OF AFFECTED BATCHES AND WHAT TO DO IF YOU HAVE BEEN AFFECTED.
PLEASE VIEW THE ATTACHED PDF DOCUMENT at base of thread for FULL details
Novo Nordisk A/S has detected that the insulin cartridge holder used in a number of NovoPen® Echo® and NovoPen® 5 batches may crack or break if exposed to certain chemicals in some household products, such as cleaning agents, sunscreen and food grease. NovoPen® Echo® and NovoPen® 5 are used for insulin treatment by people with diabetes. Novo Nordisk is already in contact with the MHRA regarding this.
Novo Nordisk urges people with diabetes using a NovoPen® Echo® and/or NovoPen® 5 from one of the affected batches to contact Novo Nordisk in order to replace the cartridge holder as some could be damaged.
A picture of the cartridge holder is shown in Figure 1.

Figure 1. Cartridge holder used for NovoPen® Echo® and NovoPen® 5.
Description of the problem:
If the cartridge holder comes in contact with certain chemicals it can crack or break. The reason for the cracking is that the plastic materials used for the cartridge holders in the affected batches can be weakened if exposed to certain chemicals found in some household products such as cleaning agents, sunscreen and food grease.
When cleaning the device as described in Instructions For Use, cracking of the cartridge holder is extremely unlikely.
Using a pen with a cracked/broken cartridge holder could result in the device delivering a smaller than intended insulin dose leading to an increase in blood sugar. The risk of experiencing high blood sugar with the use of a device with an affected cartridge holder is evaluated to be less than 0.1 %, i.e. only 1 in 1000 patients will experience high blood sugar due to an affected cartridge holder.
The warning symptoms of high blood sugar (hyperglycaemia) normally appear gradually and can be flushed, dry skin; feeling sleepy or tired; dry mouth, fruity (acetone) breath; urinating more often, feeling thirsty; losing your appetite, feeling or being sick (nausea or vomiting).
PLEASE VIEW THE ATTACHED PDF DOCUMENT (below) FOR DETAILS OF AFFECTED BATCHES AND WHAT TO DO IF YOU HAVE BEEN AFFECTED.